Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome

被引:19
|
作者
de Vega, Wilfred C. [1 ,2 ]
Erdman, Lauren [3 ,4 ]
Vernon, Suzanne D. [5 ]
Goldenberg, Anna [3 ,4 ]
McGowan, Patrick O. [1 ,2 ,6 ,7 ]
机构
[1] Univ Toronto, Dept Biol Sci, Toronto, ON, Canada
[2] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada
[3] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada
[4] SickKids Res Inst, Genet & Genome Biol, Toronto, ON, Canada
[5] Bateman Horne Ctr Excellence, Salt Lake City, UT 84102 USA
[6] Univ Toronto, Dept Psychol, Toronto, ON, Canada
[7] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON, Canada
关键词
CFS; chronic fatigue syndrome; clinical subtyping; complex disease; DNA methylation; epigenetics; health survey; myalgic encephalomyelitis; similarity network fusion; symptom heterogeneity; CHRONIC UNEXPLAINED FATIGUE; GENE-EXPRESSION SUBTYPES; EMPIRICAL DELINEATION; MULTIPLE-SCLEROSIS; SYNDROME ME/CFS; NETWORK; GENOME; MICROARRAY; BRAIN; HETEROGENEITY;
D O I
10.2217/epi-2017-0150
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aim: To identify subtypes in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) based on DNA methylation profiles and health scores. Methods: DNA methylome profiles in immune cells were integrated with symptomatology from 70 women with ME/CFS using similarity network fusion to identify subtypes. Results: We discovered four ME/CFS subtypes associated with DNA methylation modifications in 1939 CpG sites, three RAND-36 categories and five DePaul Symptom Questionnaire measures. Methylation patterns of immune response genes and differences in physical functioning and postexertional malaise differentiated the subtypes. Conclusion: ME/CFS subtypes are associated with specific DNA methylation differences and health symptomatology and provide additional evidence of the potential relevance of metabolic and immune differences in ME/CFS with respect to specific symptoms.
引用
收藏
页码:539 / 557
页数:19
相关论文
共 50 条
  • [31] Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
    Sarzi-Puttini, Piercarlo
    Marotto, Daniela
    Giorgi, Valeria
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (03) : S198 - S198
  • [33] Cognitive content in chronic fatigue syndrome/myalgic encephalomyelitis
    Gillings, K.
    Jones, C.
    Treharne, G.
    Rickards, H.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (08): : 974 - 974
  • [34] Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?
    Gandasegui, Inigo Murga
    Laka, Larraitz Aranburu
    Gargiulo, Pascual-angel
    Gomez-Esteban, Juan-Carlos
    Sanchez, Jose-Vicente Lafuente
    MEDICINA-LITHUANIA, 2021, 57 (10):
  • [35] BIOPSYCHOSOCIAL ASPECTS OF CHRONIC FATIGUE SYNDROME (MYALGIC ENCEPHALOMYELITIS)
    YEOMANS, JDI
    CONWAY, SP
    JOURNAL OF INFECTION, 1991, 23 (03) : 263 - 269
  • [36] ERYTHROCYTE RHEOLOGY IN CHRONIC FATIGUE SYNDROME/MYALGIC ENCEPHALOMYELITIS
    Brenu, Ekua Weba
    Marshall-Gradisnik, Sonya
    Ashton, Kevin John
    Ramos, Sandra B.
    Christy, Rhys M.
    Staines, Donald R.
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 : 25 - 25
  • [37] Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease
    Underhill, R. A.
    MEDICAL HYPOTHESES, 2015, 85 (06) : 765 - 773
  • [38] Biomarker Test for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (02): : 107 - 107
  • [39] Health outcomes of sensory hypersensitivities in myalgic encephalomyelitis/chronic fatigue syndrome and multiple sclerosis
    Maeda, Kensei I.
    Islam, Mohammed F.
    Conroy, Karl E.
    Jason, Leonard
    PSYCHOLOGY HEALTH & MEDICINE, 2023, 28 (10) : 3052 - 3063
  • [40] Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
    Rohrhofer, Johanna
    Hauser, Lisa
    Lettenmaier, Lisa
    Lutz, Lena
    Koidl, Larissa
    Gentile, Salvatore Alessio
    Ret, Davide
    Stingl, Michael
    Untersmayr, Eva
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)